Literature DB >> 19487655

A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.

S Nishiyama1, T Ito, T Misu, T Takahashi, A Kikuchi, N Suzuki, K Jin, M Aoki, K Fujihara, Y Itoyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19487655     DOI： 10.1212/WNL.0b013e3181a82621

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  47 in total

1.  Seroconversion of anti-aquaporin-4 antibody in NMO spectrum disorder: a case report.

Authors:  Masahiro Mori; Naoki Kawaguchi; Akiyuki Uzawa; Yuhko Nemoto; Saeko Masuda; Satoshi Kuwabara
Journal:  J Neurol       Date:  2011-11-08       Impact factor: 4.849

Review 2.  Aquaporin 4 and neuromyelitis optica.

Authors:  Marios C Papadopoulos; A S Verkman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

3.  Antibodies to aquaporin-4 in non-small cell lung cancer: a study on 50 patients.

Authors:  S Jarius; A Warth; K P Wandinger; P A Schnabel; H Hoffmann; B Wildemann; T Muley
Journal:  Neurol Sci       Date:  2010-05-27       Impact factor: 3.307

4.  Noninvasive, Targeted Creation of Neuromyelitis Optica Pathology in AQP4-IgG Seropositive Rats by Pulsed Focused Ultrasound.

Authors:  Xiaoming Yao; Matthew S Adams; Peter D Jones; Chris J Diederich; Alan S Verkman
Journal:  J Neuropathol Exp Neurol       Date:  2019-01-01       Impact factor: 3.685

5.  Blood-brain barrier resealing in neuromyelitis optica occurs independently of astrocyte regeneration.

Authors:  Anne Winkler; Claudia Wrzos; Michael Haberl; Marie-Theres Weil; Ming Gao; Wiebke Möbius; Francesca Odoardi; Dietmar R Thal; Mayland Chang; Ghislain Opdenakker; Jeffrey L Bennett; Stefan Nessler; Christine Stadelmann
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

6.  Evaluation of aquaporin-4 antibody assays.

Authors:  Patrick J Waters; Sean J Pittock; Jeffrey L Bennett; Sven Jarius; Brian G Weinshenker; Dean M Wingerchuk
Journal:  Clin Exp Neuroimmunol       Date:  2014-04-22

7.  Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders.

Authors:  G Orman; K Y Wang; Y Pekcevik; C B Thompson; M Mealy; M Levy; I Izbudak
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-16       Impact factor: 3.825

8.  Clinical relevance of serum aquaporin-4 antibody levels in neuromyelitis optica.

Authors:  Noriko Isobe; Tomomi Yonekawa; Takuya Matsushita; Katsuhisa Masaki; Satoshi Yoshimura; Jakub Fichna; Shu Chen; Jadwiga Furmaniak; Bernard Rees Smith; Jun-Ichi Kira
Journal:  Neurochem Res       Date:  2013-03-02       Impact factor: 3.996

Review 9.  Immunology of neuromyelitis optica: a T cell-B cell collaboration.

Authors:  Meike Mitsdoerffer; Vijay Kuchroo; Thomas Korn
Journal:  Ann N Y Acad Sci       Date:  2013-04       Impact factor: 5.691

Review 10.  Pain in neuromyelitis optica--prevalence, pathogenesis and therapy.

Authors:  Monika Bradl; Yoko Kanamori; Ichiro Nakashima; Tatsuro Misu; Kazuo Fujihara; Hans Lassmann; Jürgen Sandkühler
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.